Life sciences news

Agomab raises $100 million Series C to advance fibrosis-focused pipeline

Wednesday October 11th 2023

Read more
SwiftPharma launches ODIN.AI: A groundbreaking AI-augmented antibody discovery platform

Monday October 9th 2023

Read more
Agomab receives FDA Fast Track Designation for AGMB-129 in Fibrostenosing Crohn’s Disease and starts STENOVA Phase 2a clinical trial

Friday October 6th 2023

Read more
Kevin Helash commences role as Chief Executive Officer of Biotalys

Thursday October 5th 2023

Read more
Exploring 40 years of biotech excellence

Wednesday October 4th 2023

Read more
Rejuvenate Biomed announces positive results from Phase 1b clinical trial with RJx-01 in sarcopenia

Wednesday October 4th 2023

Read more
Precirix appoints leading radiopharmaceutical and oncology experts to newly formed Scientific Advisory Board

Wednesday October 4th 2023

Read more
Biotalys announces the appointment of Kevin Helash as Chief Executive Officer and Director to lead the company in its next growth phase

Monday October 2nd 2023

Read more
Your news here?

Become a flanders.bio member
Triple discovery unveils insights into type 2 diabetes

Thursday September 28th 2023

Read more
SwiftPharma and Medace sign strategic collaboration agreement for biomanufacturing and purification of promising medicinal proteins.

Wednesday September 27th 2023

Read more
Mithra Announces Presentation of Positive Data on Estetrol (E4) Native Estrogen

Wednesday September 27th 2023

Read more

More info?

Communication Coordinator